• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GSS
Click for more information
0.74% 68.5¢

GENETIC SIGNATURES LIMITED - News & Media

Market Cap $155.4M  ! watchlist Created with Sketch. Add to my watchlist

Genetic Signatures Limited is an Australia-based specialist molecular diagnostics (MDx)... Genetic Signatures Limited is an Australia-based specialist molecular diagnostics (MDx) company. The Company's principal activities include research and commercialization of identifying individual genetic signatures to identify diseases and the sale of associated products into the diagnostic and research marketplaces. The Company is focused on the development and commercialization of its platform technology, 3base. Its MDx 3base platform technology provides high-volume hospitals and pathology laboratories with the ability to screen for an array of infectious pathogens, with a high degree of specificity, in a rapid throughput (time-to-result) environment. It designs and manufactures a suite of real-time Polymerase Chain Reaction (PCR) based products for the routine detection of infectious diseases under the EasyScreen brand. Its products include EasyScreen Pan-Enteric Detection Kit, EasyScreen STI Genital Pathogen Detection, EasyScreen Viral Meningitis Detection Kit, and others. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No News & Media currently available.

(20min delay)
Last
68.5¢ 		Change
0.005(0.74%) 		Mkt cap ! $155.4M
Open High Low Value Volume
68.5¢ 68.5¢ 68.5¢ $7.891K 11.52K

Buyers (Bids)

No. Vol. Price($)
1 2851 68.5¢
 

Sellers (Offers)

Price($) Vol. No.
69.0¢ 125000 1
View Market Depth
Last trade - 14.21pm 28/11/2024 (20 minute delay) ?
GSS (ASX) Chart

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals Pro Medicus Ltd is set to roll out a suite of diagnostic imaging products across the health care system run by Trinity Health
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.